| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |